The Future of Advanced Manufacturing is Moving Towards AI Technology

 
What can go zero to 60 in 1.9 seconds, reach a top speed of more than 280 miles per hour, boasts a 1,350 combined horsepower, and is human-AI designed and 3D-printed? Welcome to advanced manufacturing and the latest vehicle revolution: the Czinger 21C. Scottsdale, Arizona, home of the Barrett-Jackson luxury car auction, is home to one of only 15 dealerships in the world that offer Czinger Vehicles.

Czinger Vehicles marks another example of how AI and other technologies impact industry and advanced manufacturing, disrupting the status quo and ushering in an exciting new future.

On this episode of DisruptED, Ron J Stefanski welcomes his high-octane guest to the program for the first of their three-episode series dedicated to the future of advanced manufacturing. Lukas Czinger is the COO and Co-founding force behind Czinger Vehicles and more recently, the COO of Divergent. Czinger joined Stefanski to discuss his career and vision for Czinger Vehicles and Divergent.

Working with his father, Kevin, Czinger puts his efforts and determination into solving automotive and manufacturing challenges.

“When we started, Kevin had this vision for what is a natural transition from analog to digital manufacturing, and why do we want to make this transition,” Czinger said. “It starts with the why first, and that was throughout a lifetime of thinking about technology, automotive, and defense manufacturing. It was based on these two principles: automotive is broken from a capital structure, a capital return standpoint because they are freezing all their spending in tooling and infrastructure upfront. And then number two, we’ve got this massive buzz around EVs, and that’s only looking at one piece of the puzzle. What really needs to be looked at is cradle-to-grave lifecycle emissions.”

During their first conversation, Stefanski and Czinger discuss…

● The process of solving manufacturing challenges through 3D printing

● Czinger’s mission to create scalable solutions through advanced manufacturing

● The potential for Divergent’s capabilities in national defense solutions

“Right now, we’re taking those steps and gearing up in aerospace defense and our relationships on the government side,” Czinger said. “Over the next six months, you are going to see Divergent’s profile change quite a bit. You’ll see government interest on a scale that you don’t typically see the government move this fast on.”

About Lukas

Lukas Czinger is a Yale graduate with a BA in electrical engineering. He Co-founded Czinger Vehicles in 2019 and received recognition as one of Forbes’s 30 Under 30 in January 2023. Czinger Vehicles is preparing to build 21C sports cars in 2023.

Follow us on social media for the latest updates in B2B!

Image

Latest

ESA
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
April 21, 2025

As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…

Read More
supply chain data analytics
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
April 21, 2025

Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…

Read More
cancer immunotherapy
What’s Next in Preclinical Cancer Immunotherapy Research?
April 19, 2025

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

Read More
vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More